Clinical Trial

A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-04
Trial Details
NCT Number NCT07446153
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Solid Tumor
Enrollment 282 participants
Start Date 2026-03-19
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-03